Orpheris is Biotechnology in United States that focus on spectrum disorders business. Founded in 2015. They cover business area such as developer, dendrimer technology, pediatric neurological disorder, clinical trial, autism spectrum disorder, therapeutic agent, reactive microglial cell, pediatric and orphan patient, a cure, neuroinflammatory disease, death, severe disability.
2015
( 9 years old in 2024 )
Spectrum Disorders
-
303 Twin Dolphin Drive
Suite 600
Redwood City, CA 94065
United States
Private
developerdendrimer technologypediatric neurological disorderclinical trialautism spectrum disordertherapeutic agentreactive microglial cellpediatric and orphan patienta cureneuroinflammatory diseasedeathsevere disability
* We use standard office opening hours in near Orpheris's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Orpheris is Biotechnology business from United States that founded in 2015 (9 years old in 2024), Orpheris business is focusing on Spectrum Disorders.
Orpheris headquarter office and corporate office address is located in 303 Twin Dolphin Drive Suite 600 Redwood City, CA 94065 United States.
Orpheris was founded in United States.
In 2024, Orpheris is currently focus on spectrum disorders sector.
Above is snippet of Google Trends for "spectrum disorders" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Orpheris, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
